DE69711411T2 - Verwendung von gamma-hydroxybuttersäureamiden in der behandlung von drogenabhängigkeit und insbesondere von alcoholismus - Google Patents
Verwendung von gamma-hydroxybuttersäureamiden in der behandlung von drogenabhängigkeit und insbesondere von alcoholismusInfo
- Publication number
- DE69711411T2 DE69711411T2 DE69711411T DE69711411T DE69711411T2 DE 69711411 T2 DE69711411 T2 DE 69711411T2 DE 69711411 T DE69711411 T DE 69711411T DE 69711411 T DE69711411 T DE 69711411T DE 69711411 T2 DE69711411 T2 DE 69711411T2
- Authority
- DE
- Germany
- Prior art keywords
- alkyl
- treatment
- drug addiction
- alcoholism
- gamma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT96MI001732A IT1283782B1 (it) | 1996-08-09 | 1996-08-09 | Uso di ammidi dell'acido gamma-idrossibutirrico nel trattamento di tossicodipendenze,ed in particolare sell'alcolismo |
PCT/EP1997/004309 WO1998006690A1 (en) | 1996-08-09 | 1997-08-07 | USE OF η-HYDROXYBUTYRIC ACID AMIDES IN THE TREATMENT OF DRUG ADDICTION AND IN PARTICULAR OF ALCOHOLISM |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69711411D1 DE69711411D1 (de) | 2002-05-02 |
DE69711411T2 true DE69711411T2 (de) | 2002-11-07 |
Family
ID=11374795
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69711411T Expired - Lifetime DE69711411T2 (de) | 1996-08-09 | 1997-08-07 | Verwendung von gamma-hydroxybuttersäureamiden in der behandlung von drogenabhängigkeit und insbesondere von alcoholismus |
Country Status (13)
Country | Link |
---|---|
US (2) | US6436998B1 (de) |
EP (1) | EP0932597B1 (de) |
JP (1) | JP4259615B2 (de) |
AT (1) | ATE215065T1 (de) |
AU (1) | AU4379097A (de) |
CA (1) | CA2263328C (de) |
DE (1) | DE69711411T2 (de) |
DK (1) | DK0932597T3 (de) |
ES (1) | ES2174287T3 (de) |
HU (1) | HU228595B1 (de) |
IT (1) | IT1283782B1 (de) |
PT (1) | PT932597E (de) |
WO (1) | WO1998006690A1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1140061T3 (da) * | 1998-12-23 | 2003-08-25 | Orphan Medical Inc | Mikrobiologisk sunde og stabile opløsninger af gamma-hydroxybutyratsalt til behandling af narcolepsi |
FR2827859B1 (fr) | 2001-07-30 | 2005-09-23 | Lipha | Derives 4-(arylthio) - ou 4-(heteroarylthio) -butyrique dans la preparation de medicaments destines au traitement du diabete |
AU2003295393A1 (en) * | 2002-11-01 | 2004-06-07 | Baylor Research Institute | Ghb treatment methods |
US7838556B2 (en) * | 2006-02-21 | 2010-11-23 | University Of Maryland, Baltimore | Ethers of 3-hydroxyphenylacetic acid as selective gamma-hydroxybutyric acid receptor ligands |
EP2062875A1 (de) * | 2007-11-13 | 2009-05-27 | LABORATORIO FARMACEUTICO C.T. S.r.l. | Neue polymorphe Formen von N-[4-(Trifluormethyl)benzyl]-4-Methoxybutyramid |
US8771735B2 (en) * | 2008-11-04 | 2014-07-08 | Jazz Pharmaceuticals, Inc. | Immediate release dosage forms of sodium oxybate |
US8778398B2 (en) * | 2008-11-04 | 2014-07-15 | Jazz Pharmaceuticals, Inc. | Immediate release formulations and dosage forms of gamma-hydroxybutyrate |
AU2011232408B2 (en) | 2010-03-24 | 2015-07-30 | Jazz Pharmaceuticals, Inc. | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances |
US8591922B1 (en) | 2012-12-14 | 2013-11-26 | Jazz Pharmacuticals, Inc. | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders |
ITMI20132041A1 (it) * | 2013-12-06 | 2015-06-07 | Ct Lab Farm Srl | Derivati dell'acido gamma-idrossibutirrico, loro preparazione e loro uso medico. |
US10398662B1 (en) | 2015-02-18 | 2019-09-03 | Jazz Pharma Ireland Limited | GHB formulation and method for its manufacture |
ITUB20152860A1 (it) | 2015-08-04 | 2017-02-04 | Laboratorio Farm C T S R L | Selezionata amide dell?acido ?-idrossibutirrico e suoi usi nel trattamento dell?abuso da alcool |
ITUA20164040A1 (it) * | 2016-06-01 | 2017-12-01 | Laboratorio Farm C T S R L | Procedimento per la preparazione di polimorfo a |
US11504347B1 (en) | 2016-07-22 | 2022-11-22 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11602513B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11602512B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
UY37341A (es) | 2016-07-22 | 2017-11-30 | Flamel Ireland Ltd | Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada |
US11986451B1 (en) | 2016-07-22 | 2024-05-21 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US20180263936A1 (en) | 2017-03-17 | 2018-09-20 | Jazz Pharmaceuticals Ireland Limited | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders |
CA3115122A1 (en) | 2018-11-19 | 2020-05-28 | Jazz Pharmaceuticals Ireland Limited | Alcohol-resistant drug formulations |
AU2020231916A1 (en) | 2019-03-01 | 2021-08-05 | Flamel Ireland Limited | Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state |
WO2023126076A1 (en) | 2022-01-03 | 2023-07-06 | Laboratorio Farmaceutico C.T. S.R.L. | Medical use of an amide of y-hydroxybutyric acid in the treatment of fragile x syndrome |
US11583510B1 (en) | 2022-02-07 | 2023-02-21 | Flamel Ireland Limited | Methods of administering gamma hydroxybutyrate formulations after a high-fat meal |
US11779557B1 (en) | 2022-02-07 | 2023-10-10 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3940258A (en) * | 1971-11-26 | 1976-02-24 | Gaf Corporation | Method for controlling aquatic weeds with N-phenylalkyl-γ-hydroxybutyramide |
JPS6016432B2 (ja) * | 1977-07-26 | 1985-04-25 | グレラン製薬株式会社 | 複素環式化合物類およびその製造法 |
DE3855875T2 (de) * | 1987-02-23 | 1997-08-28 | Ono Pharmaceutical Co | Thiazolidin-Derivate |
IT1217783B (it) | 1988-06-03 | 1990-03-30 | Farmaceutico Ct S R L Lab | Impiego di salo dell,acido gamma idrossi butirrico per la preparazione di composizioni farmaceutiche adatta ad essereimpiegate nella terapia dell,alcolismo e composizioni relative |
IT1248588B (it) * | 1991-06-28 | 1995-01-19 | Gaetano Crepaldi | Composizioni farmaceutiche per la terapia dell'astinenza, del " craving", della dipendenza da sostanze stupefacenti, da sostanze psicoattive, da nicotina e dei disturbi alimentari. |
EP0763016B1 (de) * | 1994-06-01 | 2000-01-26 | Axys Pharmaceuticals, Inc. | Zusammensetzungen und verfahren zur behandlung von durch mast-zellen verursachten krankheiten |
CZ272296A3 (en) * | 1995-09-18 | 1997-04-16 | Sankyo Co | Novel derivatives of urea exhibiting acat inhibition activity, their preparation and therapeutic and prophylactic application |
BR9814820A (pt) * | 1997-10-14 | 2000-10-03 | Welfide Corp | Compostos de piperazina e seu uso médico |
-
1996
- 1996-08-09 IT IT96MI001732A patent/IT1283782B1/it active IP Right Grant
-
1997
- 1997-08-07 EP EP97941921A patent/EP0932597B1/de not_active Expired - Lifetime
- 1997-08-07 CA CA002263328A patent/CA2263328C/en not_active Expired - Lifetime
- 1997-08-07 DE DE69711411T patent/DE69711411T2/de not_active Expired - Lifetime
- 1997-08-07 AT AT97941921T patent/ATE215065T1/de active
- 1997-08-07 AU AU43790/97A patent/AU4379097A/en not_active Abandoned
- 1997-08-07 ES ES97941921T patent/ES2174287T3/es not_active Expired - Lifetime
- 1997-08-07 US US09/242,048 patent/US6436998B1/en not_active Expired - Lifetime
- 1997-08-07 JP JP50937298A patent/JP4259615B2/ja not_active Expired - Lifetime
- 1997-08-07 WO PCT/EP1997/004309 patent/WO1998006690A1/en active IP Right Grant
- 1997-08-07 PT PT97941921T patent/PT932597E/pt unknown
- 1997-08-07 HU HU9902437A patent/HU228595B1/hu unknown
- 1997-08-07 DK DK97941921T patent/DK0932597T3/da active
-
2001
- 2001-12-11 US US10/013,971 patent/US6770784B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DK0932597T3 (da) | 2002-06-24 |
DE69711411D1 (de) | 2002-05-02 |
ATE215065T1 (de) | 2002-04-15 |
WO1998006690A1 (en) | 1998-02-19 |
CA2263328C (en) | 2006-07-25 |
CA2263328A1 (en) | 1998-02-19 |
EP0932597A1 (de) | 1999-08-04 |
HUP9902437A2 (hu) | 1999-12-28 |
AU4379097A (en) | 1998-03-06 |
US20020165224A1 (en) | 2002-11-07 |
EP0932597B1 (de) | 2002-03-27 |
PT932597E (pt) | 2002-09-30 |
ITMI961732A0 (de) | 1996-08-09 |
US6436998B1 (en) | 2002-08-20 |
JP2000516225A (ja) | 2000-12-05 |
HUP9902437A3 (en) | 2001-07-30 |
JP4259615B2 (ja) | 2009-04-30 |
ITMI961732A1 (it) | 1998-02-09 |
HU228595B1 (en) | 2013-04-29 |
US6770784B2 (en) | 2004-08-03 |
ES2174287T3 (es) | 2002-11-01 |
IT1283782B1 (it) | 1998-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69711411T2 (de) | Verwendung von gamma-hydroxybuttersäureamiden in der behandlung von drogenabhängigkeit und insbesondere von alcoholismus | |
DE69429438T2 (de) | Tricyclische carbamat-derivate zur inhibierung der g-protein funktion und für die behandlung von proliferativen erkrankungen | |
NO931151L (no) | Fremgangsmaate for fremstilling av nitrogenholdige heterocykliske forbindelser med kondenserte ringer | |
IL134635A0 (en) | A process for the preparation of acylated cyclic 1,3-dicarbonyl compounds | |
DE69911935D1 (de) | Granulatimide-derivate zur behandlung von krebs | |
MY104850A (en) | N-phenyloyrazole derivatives | |
ES2177656T3 (es) | Derivados de antraciclinona y su utilizacion en el tratamiento de la amiloidosis. | |
FI941699A0 (fi) | Atsabisyklo-aryyliasetyleeni- ja arylenyynioksiimit kolinenergisina aineina ja hoitomenetelmät | |
GR1000156B (el) | ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΝΕΩΝ ΠΑΡΑΓΩΓΩΝ ΤΡΙΚΥΚΛΙΚΩΝ ΑΜΙΝΩΝ ΤΗΣ ΤΕΤΡΑΥΔΡΟ-5,6,7,8ΝΑΦΘΟ[2,3b] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ & ΤΗΣ ΤΕΤΡΑΥΔΡΟ-6,7,8,9 5Η-ΒΕΝΖΟΚΥΚΛΟΕΠΤΑ[2,3Β] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ. | |
BG103271A (en) | Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means | |
ATE69220T1 (de) | Sechsgliedrige heterocyclische derivate von n'substituiertenn,n'-diacylhydrazinen. | |
GR3023757T3 (en) | Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents. | |
ES2190533T3 (es) | Derivados de tropano utilizables en particular para la deteccion in vivo de transportadores de dopamina. | |
NO870423D0 (no) | 5-substituert octahydroindolizin-analgetika-forbindelser og 7-keto-mellomprodukt. | |
FI860074A (fi) | Oktahydroindolizinfoereningar anvaendbara som smaertstillande medel. | |
ITMI920084A1 (it) | Alchil derivati del trazodone | |
ATE6635T1 (de) | Biologisch aktive trizyklische amine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. | |
DE69621939D1 (de) | Verwendung von prostanderivaten und deren kombination mit antibiotika in der behandlung bakterieller infektionen | |
GB1431617A (en) | Benzopyrano- and benzothiopyranoindazole n-oxides | |
ATE228359T1 (de) | Hemmung der leukotrienbiosynthese mittels harnstoffderivaten | |
ATE47863T1 (de) | Makrolide derivate. | |
KR930007920A (ko) | 광범위 살균제로서의 비스 - 이소티아졸론 | |
CA1246075A (en) | AMINOALKOXYBENZOPYRANONES USED AS ANTIPSYCHOTIC AGENTS | |
GB1410319A (en) | 6-aza-3h-1,4-benzodiazepines | |
DE3664044D1 (de) | N,n-dialkylaminoalkyl-hexahydro-5-oxo-1h-pyrrolizine-3-carboxamides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |